Home › Stocks › SXTC

SXTC — CHINA SXT PHARMACEUTICALS IN

Reported value held$1.05M
Funds holding (latest)26
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)5
Institutional value$62.87K · 20.88K sh
New / Add / Cut / Exit4 / 1 / 0 / 1 · Updated 2026-11-21
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +197100.0% (+1.97K sh)
Institutional value change Up +296700.0%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 5 SEC-registered investment managers reported holding SXTC (CHINA SXT PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $62.87K across 20.88K shares. That is +197100.0% by share count (+1.97K shares) versus the previous quarter, while reported value moved +296700.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 4 opened new positions, 1 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of CHINA SXT PHARMACEUTICALS IN (SXTC) include Citadel Advisors, Marex Group Ltd, Invesco Ltd, ranked by reported 13F value among the 26 institutional holders on this page.

SXTC is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 5 20.88K $62.87K +197100.0%
Q2 2026 2 3 $6 +50.0%
Q1 2026 3 78.17K $131.33K -99.5%
Q4 2025 8 327.57K $524.04K +35.7%
Q3 2025 10 310.84K $490.57K -58.3%
Q2 2025 3 76.72K $132.56K +1087.8%
Q1 2025 1 5.27K $13.15K +65775.0%
Q4 2024 2 10.01K $5.08K -46.4%

Over the 8 quarters shown, institutional share counts increased 109% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+65775.0%).

Top Institutional Holders (Q3 2026) — 5 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 18.21K $54.81K 0.00% New
UBS Group AG 1.97K $5.94K 0.00% Add
Robinhood Markets, Inc. 695 $2.11K 0.00% New
JPMorgan Chase & Co 4 $11 0.00% New
Citigroup Inc 1 $3 0.00% New

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 2 funds

FundSharesValuePortfolio WeightChange
Caitong International Asset Management Co., Ltd 2 $4 0.00% Add
UBS Group AG 1 $2 0.00% Hold

Q1 2026 — 3 funds

FundSharesValuePortfolio WeightChange
SABBY MANAGEMENT, LLC 78.17K $131.33K 1.53% New
UBS Group AG 1 $2 0.00% Reduce
Caitong International Asset Management Co., Ltd 1 $2 0.00% New

Q4 2025 — 8 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 150.58K $240.92K 0.00% Add
Invesco Ltd 85.33K $136.53K 0.00% Reduce
Geode Capital Management 53.67K $85.87K 0.00% Hold
XTX Topco Ltd 22.77K $36.44K 0.00% New
Virtu Financial LLC 12.36K $20.00K 0.00% Reduce
Tower Research Capital LLC (TRC) 1.83K $2.92K 0.00% Reduce
ROYAL BANK OF CANADA 818 $1.00K 0.00% New
UBS Group AG 222 $356 0.00% Add

Q3 2025 — 10 funds

FundSharesValuePortfolio WeightChange
Invesco Ltd 89.66K $140.77K 0.00% New
Geode Capital Management 53.67K $85.34K 0.00% New
Citadel Advisors 48.76K $77.53K 0.00% New
Renaissance Technologies 44.50K $69.86K 0.00% New
Virtu Financial LLC 28.98K $46.00K 0.00% Add
HRT FINANCIAL LP 26.75K $42.00K 0.00% New
TWO SIGMA SECURITIES, LLC 15.45K $24.25K 0.00% New
Tower Research Capital LLC (TRC) 2.88K $4.52K 0.00% Add
UBS Group AG 100 $157 0.00% Reduce
State of Wyoming 89 $142 0.00% New

Q2 2025 — 3 funds

FundSharesValuePortfolio WeightChange
UBS Group AG 62.60K $108.30K 0.00% Add
Virtu Financial LLC 13.97K $24.00K 0.00% New
Tower Research Capital LLC (TRC) 151 $261 0.00% New

View all 26 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
JANE STREET GROUP, LLC 18.21K — — — — — — — — — — — — — — — — — — —
UBS Group AG 1.97K 1 1 222 100 62.60K 5.27K 8 8.68K 12.57K 8 6.41K 29.87K — 17.95K 10.62K 7.72K — 51.81K 18.61K
Robinhood Markets, Inc. 695 — — — — — — — — — — — — — — — — — — —
JPMorgan Chase & Co 4 — — — — — — — 376 — — — — — — — — — — —
Citigroup Inc 1 — — — — — — — — — — — — — — — — — 34.20K —
Citadel Advisors — — — 150.58K 48.76K — — — — 16.11K — — 191.34K — 24.41K — — — 266.28K —
Marex Group Ltd — — — — — — — — — — — 41.29K — — — — — — — —
Invesco Ltd — — — 85.33K 89.66K — — — — — — — — — — — — — — —
SABBY MANAGEMENT, LLC — — 78.17K — — — — — — — — — — — — — — — — —
Renaissance Technologies — — — — 44.50K — — — — — — — — 10.54K 34.50K — 21.57K 29.47K 451.50K 21.40K
Geode Capital Management — — — 53.67K 53.67K — — — — — — — — — — — — — 26.64K 26.64K
Virtu Financial LLC — — — 12.36K 28.98K 13.97K — — — 31.61K — — — — — — — — — —
HRT FINANCIAL LP — — — — 26.75K — — — — — — — 48.51K — — — — — — —
XTX Topco Ltd — — — 22.77K — — — — — — — — — — — — — — — —
TWO SIGMA SECURITIES, LLC — — — — 15.45K — — — — — — — 49.97K — — — — — — —
BANK OF MONTREAL /CAN/ — — — — — — — 10.00K 10.00K 10.00K — — — — — — — — — —
GSA CAPITAL PARTNERS LLP — — — — — — — — 12.30K — — — — — — — — — — —
Baader Bank Aktiengesellschaft — — — — — — — — 15.16K — — — 12.92K — — — — — — —
LEVEL FOUR ADVISORY SERVICES, LLC — — — — — — — — — — — — 42.77K — — — — — — —
Tower Research Capital LLC (TRC) — — — 1.83K 2.88K 151 — — — — — — — — — — — — — —

Download holders (CSV)

FAQ

Which funds hold SXTC?

As of 2026-Q3, 5 institutional funds reported holding SXTC (CHINA SXT PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $62.87K.

How many shares of SXTC do institutions own?

13F filers reported 20.88K shares of SXTC, worth $62.87K in aggregate at the end of 2026-Q3.

Is institutional ownership of SXTC rising or falling?

Share counts moved +197100.0% versus the prior quarter — accumulation.

Who are the top institutional holders of SXTC?

The largest 13F holders are Citadel Advisors, Marex Group Ltd, Invesco Ltd, SABBY MANAGEMENT, LLC, Geode Capital Management; the top 25 are ranked at the top of this page.

Who are the major shareholders of CHINA SXT PHARMACEUTICALS IN?

The major shareholders of CHINA SXT PHARMACEUTICALS IN (SXTC) by reported 13F value are Citadel Advisors, Marex Group Ltd, Invesco Ltd, SABBY MANAGEMENT, LLC, Geode Capital Management, among 26 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own SXTC" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/SXTC/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →